Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma

  • Makoto Nakagawa
  • , Fumihiko Nakatani
  • , Hironori Matsunaga
  • , Takahiko Seki
  • , Makoto Endo
  • , Yoko Ogawara
  • , Yukino Machida
  • , Takuo Katsumoto
  • , Kazutsune Yamagata
  • , Ayuna Hattori
  • , Shuhei Fujita
  • , Yukiko Aikawa
  • , Takamasa Ishikawa
  • , Tomoyoshi Soga
  • , Akira Kawai
  • , Hirokazu Chuman
  • , Nobuhiko Yokoyama
  • , Suguru Fukushima
  • , Kenichiro Yahiro
  • , Atsushi Kimura
    • Eijiro Shimada, Takeshi Hirose, Toshifumi Fujiwara, Nokitaka Setsu, Yoshihiro Matsumoto, Yukihide Iwamoto, Yasuharu Nakashima, Issay Kitabayashi

Research output: Contribution to journal › Article › peer-review

61   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases